Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Non-Current Deffered Revenue (2020 - 2025)

Cellebrite DI's Non-Current Deffered Revenue history spans 6 years, with the latest figure at $49.5 million for Q4 2025.

  • Quarterly Non-Current Deffered Revenue rose 9.46% to $49.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.5 million through Dec 2025, up 9.46% year-over-year, with the annual reading at $49.5 million for FY2025, 9.46% up from the prior year.
  • Non-Current Deffered Revenue came in at $49.5 million for Q4 2025, up from $45.2 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $49.5 million in Q4 2025 to a low of $34.4 million in Q3 2021.
  • The 5-year median for Non-Current Deffered Revenue is $43.7 million (2022), against an average of $42.5 million.
  • Year-over-year, Non-Current Deffered Revenue increased 15.78% in 2022 and then fell 3.93% in 2024.
  • Cellebrite DI's Non-Current Deffered Revenue stood at $36.4 million in 2021, then grew by 15.78% to $42.2 million in 2022, then increased by 11.68% to $47.1 million in 2023, then fell by 3.93% to $45.2 million in 2024, then grew by 9.46% to $49.5 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Non-Current Deffered Revenue are $49.5 million (Q4 2025), $45.2 million (Q4 2024), and $47.1 million (Q4 2023).